Azithromycin for severe RSV breathing failure in young children
Treatments studied
Part of Infections clinical trials.
This trial tests whether azithromycin (an antibiotic) can improve outcomes for babies and young children in the ICU who have RSV causing serious breathing problems. It mainly looks at children who start strong breathing support soon after RSV symptoms begin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a child in the ICU with a confirmed RSV infection (a positive nasal swab test)
- Be needing high-level breathing support like a breathing machine, BiPAP/CPAP, or high-flow oxygen
- Start the study within 48 hours of ICU admission and starting the breathing support
- Have RSV symptoms that started less than 5 days ago
- Be between newborn and age 2 (and if under 1 week old, be discharged home after birth)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an antiviral drug called Ziresovir in adults with RSV who have health conditions that make them high-risk, such as lung disease, heart disease, or a weakened immune system. It aims to see if the drug can reduce symptoms like coughing and shortness of breath.
This trial tests if an inhaled interferon solution can help children under 2 years old with a moderate to severe RSV lung infection. It aims to reduce symptoms like cough and trouble breathing.
This trial tests whether adding the antibiotic azithromycin to standard asthma treatments helps children with severe asthma in the pediatric intensive care unit (PICU) recover faster. It is for children ages 3 to 17 who are already receiving strong asthma medicines and steroids.
This trial tests whether the antibiotic azithromycin can help children in the hospital who are having asthma-like breathing symptoms. If you qualify, your child may get azithromycin as part of the study and will be monitored closely for side effects and breathing improvement.
This trial tests whether a low-dose antibiotic (azithromycin) can prevent lung infections in young children with structural lung damage. It aims to see if taking it regularly can keep their lungs healthier and reduce the need for antibiotics.
This study tests a medicine called AK0529 for babies and toddlers hospitalized with RSV. It aims to see if the drug helps them recover faster and is safe for this age group.
Hear when a new Respiratory Syncytial Virus Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.